<?xml version="1.0" encoding="UTF-8"?>
<p id="Par140">GSH inhibits the viral apoptosis induced by IVs and the production of IV particles. It also depresses the expression of viral matrix proteins, caspase cascades, and Fas induction [
 <xref ref-type="bibr" rid="CR52">52</xref>]. Moreover, nutritional supplements that induce GSH may afford resistance to the major pathogenic processes of H5N1 [
 <xref ref-type="bibr" rid="CR183">183</xref>]. Bakuchiol, a phenolic isoprenoid, activates the Nrf2 pathway and blocks IV infection, which suggests that bakuchiol has antiviral activity [
 <xref ref-type="bibr" rid="CR28">28</xref>]. Overexpression of Nrf2 or the addition of sulforaphane and EGCG decreases the replication of, and protein synthesis in, IVs [
 <xref ref-type="bibr" rid="CR54">54</xref>] (
 <bold>Fig.</bold>
 <xref rid="Fig2" ref-type="fig">
  <bold>2</bold>
 </xref>). Moreover, Nrf2 knockdown increases the entry and replication of IVs and enhances IV-induced pulmonary cell injury [
 <xref ref-type="bibr" rid="CR54">54</xref>, 
 <xref ref-type="bibr" rid="CR141">141</xref>]. Nrf2 is also a factor in the outcome of IV-infected mice after exposure to cigarette smoke [
 <xref ref-type="bibr" rid="CR141">141</xref>]. Nrf2-deficient mice exhibit more severe bronchial inflammation, permeability damage in the lungs, mucus hypersecretion, and higher mortality rates after IV infection and cigarette smoke exposure than do wild-type mice [
 <xref ref-type="bibr" rid="CR141">141</xref>]. Taken together, these results suggest that the Nrf2-mediated antioxidant pathway plays a critical role in suppressing IV-induced LI under oxidative conditions, such as cigarette smoke exposure [
 <xref ref-type="bibr" rid="CR48">48</xref>, 
 <xref ref-type="bibr" rid="CR141">141</xref>, 
 <xref ref-type="bibr" rid="CR182">182</xref>â€“
 <xref ref-type="bibr" rid="CR184">184</xref>]. 
</p>
